Earnings Ahead

TEVA - Teva Pharmaceutical Industries Limited

10.18 0.13 1.29

Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

About

Profile

By integrating innovation, quality and accessibility, we improve health worldwide like no one else.


Headquarters

Petah Tikva, Israel


Intraday

High
-
Low
-

52-week

High
-
Low
-

TEVA



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Biggest stock movers today: Plug Power, Paramount Global, Google parent Alphabet, and more
  • Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M
  • Teva to divest API unit to focus on core business strengths
  • Teva earnings preview: Israeli drugmaker to report early Wednesday
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • Watch GSK amid evidence hearing on Zantac litigation
  • Teva raised to Buy at Jefferies citing a positive setup ahead of 2024 outlook
  • GSK, Teva, AstraZeneca under Senate probe over asthma inhaler pricing
  • J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up
  • Piper Sandler raises Teva to neutral, stock up 4%
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Corcept Therapeutics plunges after loss in patent battle with Teva
  • Europe revokes approvals for generics of Biogen's multiple sclerosis drug Tecfidera
  • AbbVie, AstraZeneca targeted for improper use of drug patents
  • AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
  • Teva analysis shows migraine drug as effective in obese patients as non-obese
  • Purdue Pharma bankruptcy settlement heads to Supreme Court review
  • Teva raised to Buy at UBS on brand transition
  • Teva gains U.S. approval for generic version of osteoporosis injection
  • Teva inks $125M deal with Royalty Pharma to develop antipsychotic drug
Date Price Open High Low Vol Change ER
May 26, 2023 7.45 7.45
7.5
7.33
14.8M 1.64%
May 25, 2023 7.33 7.46
7.5
7.25
20.8M -3.17%
May 24, 2023 7.57 7.64
7.65
7.5
11.3M -1.56%
May 23, 2023 7.69 7.92
7.97
7.68
16.3M -3.27%
May 22, 2023 7.95 8.03
8.06
7.87
13.3M 0.51%
 
May 19, 2023 7.91 8.3
8.36
7.89
77.7M -4.24%
May 18, 2023 8.26 8.45
8.76
8.23
33.7M 1.60%
May 17, 2023 8.13 8.2
8.2
7.99
9.1M 0%
May 16, 2023 8.13 8.01
8.18
8.01
18.7M 0.74%
May 15, 2023 8.07 8.04
8.18
8.02
10.6M 0.50%
May 12, 2023 8.03 8.14
8.19
7.91
18.0M -2.19%
May 11, 2023 8.21 8.41
8.42
8.11
14.7M -1.68%
May 10, 2023 8.35 8.33
8.51
8.02
26.3M -8.24%
May 9, 2023 9.1 9.02
9.21
8.97
8.3M 0.44%
May 8, 2023 9.06 8.84
9.09
8.84
10.1M 3.31%
May 5, 2023 8.77 8.75
8.82
8.7
5.7M 1.15%
May 4, 2023 8.67 8.74
8.78
8.6
5.7M -1.48%
May 3, 2023 8.8 8.83
8.93
8.73
6.5M 0%
May 2, 2023 8.8 8.78
8.83
8.69
7.0M -0.45%
May 1, 2023 8.84 8.77
8.9
8.72
5.1M 1.26%
Apr 28, 2023 8.73 8.49
8.78
8.49
9.5M 2.46%
Apr 27, 2023 8.52 8.28
8.61
8.19
7.2M 3.78%
Apr 26, 2023 8.21 8.22
8.25
8.13
6.2M -0.24%
Apr 25, 2023 8.23 8.31
8.35
8.2
5.8M -1.44%
Apr 24, 2023 8.35 8.32
8.35
8.27
5.4M 0%
Apr 21, 2023 8.35 8.3
8.41
8.3
4.0M 0%
Apr 20, 2023 8.35 8.35
8.43
8.31
7.9M -1.65%
Apr 19, 2023 8.49 8.47
8.53
8.41
11.7M -0.59%
Apr 18, 2023 8.54 8.55
8.62
8.49
13.6M 0.47%
Apr 17, 2023 8.5 8.35
8.56
8.29
12.0M 2.53%
Apr 14, 2023 8.29 8.6
8.69
8.1
35.0M -10.48%
Apr 13, 2023 9.26 9.42
9.47
9.23
9.2M -1.07%
Apr 12, 2023 9.36 9.56
9.6
9.27
7.7M -1.16%
Apr 11, 2023 9.47 9.53
9.59
9.46
6.8M 0.64%
Apr 10, 2023 9.41 9.27
9.45
9.22
5.8M 1.51%
Apr 6, 2023 9.27 9.27
9.34
9.24
8.0M 0.76%
Apr 5, 2023 9.2 9.15
9.24
9.07
5.4M 1.10%
Apr 4, 2023 9.1 9.18
9.22
9.02
10.3M -0.22%
Apr 3, 2023 9.12 8.95
9.17
8.9
13.5M 3.05%
Mar 31, 2023 8.85 8.88
8.9
8.8
5.4M 0.34%
Mar 30, 2023 8.82 8.92
8.97
8.79
7.3M -0.23%
Mar 29, 2023 8.84 8.75
8.9
8.73
21.6M 0.91%
Mar 28, 2023 8.76 8.69
8.85
8.69
7.8M 0.34%
Mar 27, 2023 8.73 8.62
8.77
8.55
8.8M 3.44%
Mar 24, 2023 8.44 8.42
8.54
8.28
7.8M -1.06%
Mar 23, 2023 8.53 8.76
8.83
8.4
10.4M -2.29%
Mar 22, 2023 8.73 8.93
9
8.73
6.9M -0.8%
Mar 21, 2023 8.8 8.65
8.98
8.61
13.0M 3.17%
Mar 20, 2023 8.53 8.36
8.65
8.27
19.6M 2.03%
Mar 17, 2023 8.36 8.43
8.45
8.3
8.7M -1.65%
Mar 16, 2023 8.5 8.59
8.59
8.36
10.8M -1.96%
Mar 15, 2023 8.67 8.7
8.73
8.51
12.6M -2.69%
Mar 14, 2023 8.91 9.05
9.12
8.83
8.8M -0.34%
Mar 13, 2023 8.94 9.07
9.1
8.9
12.7M -1.97%
Mar 10, 2023 9.12 9.3
9.35
9.08
7.8M -2.15%
Mar 9, 2023 9.32 9.64
9.67
9.3
5.9M -3.42%
Mar 8, 2023 9.65 9.51
9.69
9.34
8.1M 2.22%
Mar 7, 2023 9.44 9.79
9.83
9.35
13.9M -4.74%
Mar 6, 2023 9.91 10.07
10.14
9.86
7.4M -1.29%
Mar 3, 2023 10.04 10
10.07
9.93
5.3M 0%